Show simple item record

dc.contributor.advisorMerzaban, Jasmeen
dc.contributor.authorJalal Ahmed, Heba M.
dc.date.accessioned2012-12-10T13:00:47Z
dc.date.available2012-12-10T13:00:47Z
dc.date.issued2012-11
dc.identifier.citationJalal Ahmed, H. M. (2012). Using Proteomics To Elucidate Critical Signaling Pathways. KAUST Research Repository. https://doi.org/10.25781/KAUST-5T4I7
dc.identifier.doi10.25781/KAUST-5T4I7
dc.identifier.urihttp://hdl.handle.net/10754/255084
dc.description.abstractDespite important advances in the therapy of acute myeloid leukemia (AML) the majority of patients will die from their disease (Appelbaum, Rowe, Radich, & Dick, 2001). Characterization of the aberrant molecular pathways responsible for this malignancy provides a platform to discover alternative treatments to help alter the fate of patients. AML is characterized by a blockage in the differentiation of myeloid cells resulting in the accumulation of highly proliferating immature hematopoietic cells. Since treatments such as chemotherapy rarely destroy the leukemic cells entirely, differentiation induction therapy has become a very attractive treatment option. Interestingly, previous experiments have shown that ligation of CD44, a cell surface glycoprotein strongly expressed on all AML cells, with anti-CD44 monoclonal antibodies (mAbs) could reverse this block in differentiation of leukemic blasts regardless of the AML subtype. To expand the understanding of the cellular regulation and circuitry involved, we aim to apply quantitative phosphoproteomics to monitor dynamic changes in phosphorylation state in response to anti-CD44 treatment. Protein phosphorylation and dephosphorylation is a highly controlled biochemical process that responds to various intracellular and extracellular stimuli. As phosphorylation is a dynamic process, quantification of these phosphorylation events would be vastly insightful. The main objective of this project is to determine the differentiation-dependent phosphoproteome of AML cells upon treatment of cells with the anti-CD44 mAb.In these experiments, optimization of protein extraction, phosphopeptide enrichment and data processing and analysis has been achieved. The primary results show successful phosphoproteome extraction complemented with efficient phosphopeptide enrichment and informative data processing. Further quantification with stable isotope labeling techniques is anticipated to provide candidates for targeted therapy.
dc.language.isoen
dc.subjectPhosphoproteins
dc.subjectSignaling
dc.subjectLeukemia
dc.titleUsing Proteomics To Elucidate Critical Signaling Pathways
dc.typeThesis
dc.contributor.departmentBiological and Environmental Science and Engineering (BESE) Division
thesis.degree.grantorKing Abdullah University of Science and Technology
dc.contributor.committeememberGadhoum, Samah Z.
dc.contributor.committeememberGehring, Christoph A
thesis.degree.disciplineBioscience
thesis.degree.nameMaster of Science


Files in this item

Thumbnail
Name:
ThesisHebaAhmed.pdf
Size:
1.249Mb
Format:
PDF
Description:
Full Thesis
Thumbnail
Name:
ApprovalHebaAhmed.pdf
Size:
147.4Kb
Format:
PDF
Description:
Approval Form

This item appears in the following Collection(s)

Show simple item record